BNET Industries
Market Cap:$422.3M
Last Fiscal Year Sales:$97.0M
- Public
- US
Dow Jones Description
SurModics is a leading provider of drug delivery and surface modification technologies to the healthcare industry. In November 2008, we announced a change in our organizational structure into four clinically and market focused business units: Cardiovascular, Ophthalmology, In Vitro Technologies, and SurModics Pharmaceuticals (formerly Brookwood Pharmaceuticals). We believe that this structure will improve the visibility, marketing and adoption of the Companys broad array of technologies within specific markets and help our customers in the medical device, pharmaceutical and life science industries better solve unmet clinical needs. In addition, a new centralized research and development function has been formed to serve the needs of the Companys clinically and market focused business units. SurModics Pharmaceuticals research and development operations remained unchanged. The reorganization change announced in November 2008 resulted in the Company being comprised of new operating segments. ...
Number of Employees 254
Peer Companies
NAICS Code Lessors of Nonfinancial Intangible Assets (except Copyrighted Works): 533110
Recent Events
-
SurModics signs license agreement with NuPathe for long-acting delivery (LADTM) technology
-
Barrington Research Downgrades SurModics SRDX to Market Perform
-
SurModics enters license and development agreement with Roche and Genentech
-
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
-
Genentech inks licensing deal with SurModics
-
SurModics inks $200M licensing deal with Genetech
-
SRDX: License and Development Agreement with Roche and Genentech
-
UPDATE 1-Church & Dwight settles with Abbott Labs, SurModics
-
SurModics Reports Third Quarter 2009 Results
News & Analysis
Filter by
surmodics inc. - All News and Analysis
SurModics, Inc.Q4 2009 Earnings Call Transcript
Seeking Alpha
- 2009-11-04
Question-and-Answer SessionOperator Operator Instructions Your first question comes from Richard Rinkoff with Craig-Hallum Group. Richard Rinkoff - Craig-Hallum Group I want to clarify something; did you say that you received $1.25 million in basically back payments from Abbott in the fourth quarter? Philip Ankeny Yes, essentially....
SurModics Q2 2009 Earnings Transcript
Seeking Alpha
- 2009-07-30
SurModics, Inc. SRDX Q3 2009 Earnings Call June 29, 2009 05:00 AM ET
SurModics Q2 2009 Earnings Transcript
Seeking Alpha
- 2009-07-30
Question-and-Answer SessionOperator Thank you sir. We will now begin the question-and-answer session. Operator Instructions. And our first question is from Ross Taylor from CL Kings. Please go ahead. Ross Taylor - CL Kings & Associates I have two or three questions. First related to some of the financials, R&D...
SurModics Inc. F2Q09 (Qtr End 03/31/09) Earnings Call Transcript
Seeking Alpha
- 2009-04-30
Question-and-Answer SessionOperator Operator instructions Our first question is from the line of Rick Rinkoff with Craig-Hallum. Rick Rinkoff – Craig-Hallum Well, congratulations on a better quarter than one before that. I had a couple of questions here, first of all you said the R&D includes a little bit of...
SurModics, Inc. F1Q09 (Qtr End 12/31/08) Earnings Call Transcript
Seeking Alpha
- 2009-01-28
Question-and-Answer SessionOperator Thank you, sir. Ladies and gentlemen we will now begin the question-and-answer session. Operator instructions. Our first question comes from the line of Ross Taylor with C.L. King, please go ahead. Ross Taylor – C.L. King & Associates, Inc. Hi. I got a couple of questions. First,...
SurModics, Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
Seeking Alpha
- 2008-11-24
Question-and-Answer SessionOperator Operator instructions And our first question comes from the line of Ross Taylor with C.L. King; please go ahead. Ross Taylor – C.L. King Hi, I’ve got a couple of questions. I’ll try to keep them brief. First of all, why did the Abbott revenues dropped so...
SurModics Inc. F3Q08 (Qtr End 6/30/08) Earnings Call Transcript
Seeking Alpha
- 2008-07-28
Question-and-Answer SessionOperator Thank you, sir. Operator Instructions And our first question comes from Steve Ogilvie with ThinkEquity. Go ahead please. Steve Ogilvie - ThinkEquity Hey, guys. Just a few accounting things to get out of the way first, could you clarify on the $9 million payment, you said it's...
SurModics Inc. F2Q08 (03/31/08) Earnings Call Transcript
Seeking Alpha
- 2008-04-28
Question-and-Answer Session Operator Thank you, sir. Operator Instructions. Our first question comes from the line of Richard Rinkoff with Craig-Hallum. Please go ahead. Richard Rinkoff - Craig-Hallum Thank you. On the orthopedic product, did any money change hands when you terminated the agreement, and are you considering doing clinical...
SurModics to Present at the 2008 Association for Research in Vision and Ophthalmology Meeting
- 2008-04-24
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq: SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that two posters and one paper will be presented at the 2008 Association for Research in Vision and Ophthalmology ARVO Meeting being held April 27 -...
SurModics F1Q08 (Qtr End 12/31/07) Earnings Call Transcript
Seeking Alpha
- 2008-01-23
Question-and-Answer SessionOperator We will now begin the question-and-answer session. Operator Instructions Our first question comes from the line of Richard Rinkoff with Craig-Hallum. Please go ahead. Richard Rinkoff - Craig-Hallum Thank you. A couple of questions. Orthopedic: anything new there? Bruce Barclay Continues to progress actively in terms of...
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
